taspine has been researched along with Liver Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, B; Liu, R; Liu, Y; Wang, W; Zhang, Y | 1 |
| Dai, BL; He, LC; Wang, N; Zhang, YM | 1 |
| He, HZ; Wang, N; Zhang, J; Zhang, YM; Zheng, L | 1 |
3 other study(ies) available for taspine and Liver Neoplasms
| Article | Year |
|---|---|
Taspine derivative TAS9 regulates cell growth and metastasis of human hepatocellular carcinoma.
Topics: Alkaloids; Anticarcinogenic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Humans; Liver; Liver Neoplasms; MAP Kinase Signaling System; Neoplasm Invasiveness; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction | 2015 |
[Effect of taspine derivatives on human liver cancer SMMC7721].
Topics: Alkaloids; Antineoplastic Agents; Carcinoma, Hepatocellular; Caulophyllum; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Epidermal Growth Factor; Flow Cytometry; Humans; Liver Neoplasms; Polymerase Chain Reaction; RNA, Messenger; Vascular Endothelial Growth Factor A | 2011 |
Tas13D inhibits growth of SMMC-7721 cell via suppression VEGF and EGF expression.
Topics: Alkaloids; Animals; Blotting, Western; Carcinoma, Hepatocellular; Cell Movement; Cell Proliferation; Enzyme-Linked Immunosorbent Assay; Epidermal Growth Factor; ErbB Receptors; Humans; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A | 2012 |